文献速递生殖医学

重组LH补充对卵巢低反应者累积活产率的影响:大型真实世界研究

Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study.
PubMed 文献 · Reprod Biomed Online · 2020-08-29

该回顾性多中心对照研究纳入法国12个ART中心的9787个卵巢低反应(POR)刺激周期,比较FSH-α联合或单用促黄体生成素-α的累积活产率(CLBR)。按PROsPeR评分分层后发现,LHS对中度和重度POR患者的CLBR有显著获益,轻度患者无显著获益。

要点

  • LHS对中度POR患者CLBR有显著获益(14.3% vs 11.3%,OR=1.37)。
  • LHS对重度POR患者CLBR获益更显著(9.8% vs 4.4%,OR=2.40)。
  • 轻度POR患者LHS无显著获益(18.8% vs 19.6%,OR=0.95)。

核心结论

  • LHS可显著提高中度和重度卵巢低反应患者的累积活产率。

研究设计与样本

  • 回顾性多中心对照研究,使用法国12个ART中心注册数据,按意向性治疗原则纳入9787个POR刺激周期(5218 LHS,4569 单用FSH-α)。
  • POR按ESHRE Bologna标准定义,并按PROsPeR评分分为轻度、中度和重度三类。

主要发现

  • 33.0%、52.4%和14.6%的周期分别归入轻度、中度和重度PROsPeR类别。
  • LHS获益与基线严重程度存在交互作用(交互检验P=0.007)。
  • 中度POR:CLBR 14.3% vs 11.3%,OR=1.37(95%CI 1.07-1.75),RR=1.29,P=0.013。
  • 重度POR:CLBR 9.8% vs 4.4%,OR=2.40(95%CI 1.48-3.89),RR=1.89,P<0.001。
  • 轻度POR:CLBR 18.8% vs 19.6%,OR=0.95(95%CI 0.78-1.15),RR=0.95,P=0.60。

关键数值与推荐

  • POR定义采用ESHRE Bologna标准。
  • 严重程度分类采用PROsPeR评分。
  • 主要终点为同一次卵巢刺激的新鲜和冷冻胚胎相关的累积活产率。

临床怎么用

  • 对于中度至重度卵巢低反应患者,在控制性卵巢刺激中可考虑补充重组LH以改善累积活产率。
  • 轻度卵巢低反应患者补充LH未见显著获益,应个体化决策。

局限性

  • 回顾性研究设计可能存在残余混杂。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: The benefit of LH supplementation (LHS) over sole use of FSH during controlled ovarian stimulation (COS) remains controversial. Meta-analyses have provided some evidence that the benefit of LHS is limited to women with poor ovarian response (POR). This study aimed to assess the effectiveness of LHS on cumulative live birth rate (CLBR) in POR using a large controlled study in a real-world context. DESIGN: This retrospective multicentre controlled study used data from registries at 12 French ART centres. All instances of POR undergoing ovarian stimulation and treated with follitrophin-alfa (FSH-α) with or without lutrophin-α were selected following an intention-to-treat principle. POR was defined according to the ESHRE Bologna criteria, and classified into three categories (Mild, Moderate and Severe) according to the Poor Responder Outcome Prediction (PROsPeR) score. The primary end-point was the CLBR associated with fresh and frozen embryos originating from the same ovarian stimulation. RESULTS: A total of 9787 instances of ovarian stimulation (5218 LHS, 4569 FSH-α only) were analysed, 33.0%, 52.4% and 14.6% being allocated to the Mild, Moderate and Severe PROsPeR categories, respectively. Using a mixed logistic model and adjusting for matched subclasses and baseline POR severity, it was found that the benefit of LHS compared with use of FSH alone differed between baseline severity categories (interaction test, P = 0.007): a significant benefit of LHS for CLBR was found for patients in the Moderate (14.3% versus 11.3%, odds ratio [OR] = 1.37, 95% confidence interval [CI] 1.07-1.75, risk ratio [RR] = 1.29, P = 0.013) and Severe (9.8% versus 4.4%, OR = 2.40, 95% CI- 1.48-3.89, RR = 1.89, P < 0.001) categories, but not for the Mild category (18.8% versus 19.6%, OR = 0.95, 95% CI 0.78-1.15, RR = 0.95, P = 0.60). CONCLUSION: LHS has a significant effect on increasing CLBR in moderately and severely poor ovarian responders.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Arvis P, Massin N, Lehert P, et al. Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study. Reprod Biomed Online. 2020. PMID: 33431337. doi:10.1016/j.rbmo.2020.08.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。